Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125492051 | 12549205 | 1 | I | 201507 | 20160706 | 20160712 | 20160712 | EXP | PHEH2016US016859 | NOVARTIS | 54.09 | YR | F | Y | 0.00000 | 20160712 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125492051 | 12549205 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | UNK | U | 21588 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125492051 | 12549205 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125492051 | 12549205 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125492051 | 12549205 | Cerebrovascular accident | |
125492051 | 12549205 | Lip swelling | |
125492051 | 12549205 | Nervous system disorder | |
125492051 | 12549205 | Peripheral swelling | |
125492051 | 12549205 | Seizure | |
125492051 | 12549205 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |